标普生物科技LOF(161127)
动态评分: 5.92分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2023-12-31 | IONS | Ionis Pharmaceuticals Inc | 353.48 | 1.12% |
2023-12-31 | NUVL | Nuvalent Inc-A | 354.32 | 1.12% |
2023-12-31 | PTCT | PTC Therapeutics Inc | 355.03 | 1.12% |
2023-12-31 | BMRN | 拜玛林制药 | 352.93 | 1.12% |
2023-12-31 | ABBV | 艾伯维 | 353.21 | 1.12% |
2023-12-31 | BEAM | Beam Therapeutics Inc | 350.38 | 1.11% |
2023-12-31 | GILD | 吉利德科学 | 348.79 | 1.1% |
2023-12-31 | IMGN | ImmunoGen Inc | 345.31 | 1.09% |
2023-12-31 | CRSP | CRISPR Therapeutics AG | 329.96 | 1.04% |
2023-12-31 | SNDX | Syndax Pharmaceuticals Inc | 330.3 | 1.04% |
2023-12-31 | CRNX | Crinetics Pharmaceuticals Inc | 329.34 | 1.04% |
2023-12-31 | APLS | Apellis Pharmaceuticals Inc | 324.63 | 1.03% |
2023-12-31 | ARDX | Ardelyx Inc | 323.13 | 1.02% |
2023-12-31 | TWST | Twist Bioscience Corp | 320.67 | 1.01% |
2023-12-31 | HALO | 奥洛兹美医疗 | 314.73 | 1% |
2023-12-31 | UTHR | 联合治疗 | 309.61 | 0.98% |
2023-12-31 | IRWD | Ironwood Pharmaceuticals Inc-A | 305.36 | 0.97% |
2023-12-31 | VKTX | Viking Therapeutics Inc | 292.55 | 0.93% |
2023-12-31 | NVAX | 诺瓦瓦克斯医药 | 294.27 | 0.93% |
2023-12-31 | DVAX | 德纳维制药 | 287.31 | 0.91% |
公告&资料
